Show simple item record

dc.contributor.authorPato Cour, Esperanza
dc.contributor.authorMartín Martínez, Auxiliadora
dc.contributor.authorBorrego Sanz, Lara
dc.contributor.authorMartínez Costa, Lucía
dc.contributor.authorEsteban Ortega, Mar
dc.contributor.authorSánchez Costa, Jesús T.
dc.contributor.authorCordero Coma, Miguel
dc.contributor.authorFonollosa Calduch, Alejandro
dc.contributor.authorDíaz Valle, Teresa
dc.contributor.authorRodríguez González, Fayna
dc.contributor.authorSainz de la Mata, Maite
dc.contributor.authorDíaz Valle, David
dc.contributor.authorGonzález Ocampo, Samuel
dc.contributor.authorLópez Sierra, Sara
dc.contributor.authorGarcía Lozano, Isabel
dc.contributor.authorGarzo García, Irene
dc.contributor.authorArtaraz Beobide, Joseba Iñaki
dc.contributor.authorGurrea Almela, María
dc.contributor.authorTejera, Marta
dc.contributor.authorMoll Udina, Aina
dc.contributor.authorValls Pascual, Elia
dc.contributor.authorMuñoz Fernández, Santiago
dc.contributor.authorMéndez Fernández, Rosalía
dc.date.accessioned2023-03-23T16:21:53Z
dc.date.available2023-03-23T16:21:53Z
dc.date.issued2023-04
dc.identifier.citationOphthalmology and Therapy 12(2) : 1045-1055 (2023)es_ES
dc.identifier.issn2193-8245
dc.identifier.issn2193-6528
dc.identifier.urihttp://hdl.handle.net/10810/60469
dc.description.abstractIntroduction Uveitis is the inflammation of the middle layer of the eye, the uvea, and is a major cause of blindness. None of the instruments used in clinical practice are, in themselves, sufficient to evaluate the course of uveitis. Therefore, it is necessary to develop instruments enabling standardized measurement of inflammatory activity. We developed a composite disease activity index for patients with uveitis known as UVEDAI, which considers the overall activity of the eye. The objective of this study was to validate the composite index of ocular inflammation, UVEDAI. Methods A multicenter cross-sectional study involving eight Spanish tertiary hospitals. Sixty-two patients aged ≥ 18 years with acute uveitis were recruited. Participants gave informed consent before participating in the study. A full ophthalmological examination was performed by two ophthalmologists to determine inflammatory activity: one used the UVEDAI score and the other used clinical judgment. The ophthalmologists did not share their findings with each other to avoid introducing bias into the analysis. Construct validity was established by means of factor analysis. The criterion validity of the index was determined using an ordinal multivariate regression model, in which the dependent variable was the degree of uveal inflammation (mild, moderate, or high/severe). Cut-off points were determined for the UVEDAI and for the receiver operating characteristic (ROC) curves. Results Sixty-two patients were included. Total variance with the three components accounted for 80.32% of the construct validity. Each of the three components identified one type of eye involvement. The discriminatory capacity of UVEDAI was 0.867 (95% CI 0.778; 0.955 p < 0.001) for mild versus moderate–high and 0.946 (95% CI 0.879; 1.000 p < 0.001) for high versus mild–moderate. Conclusions The variables included in UVEDAI enable ocular inflammatory activity to be described with a high degree of accuracy. The index may be used to evaluate and classify this activity with considerable discriminatory power.es_ES
dc.description.sponsorshipWe would like to acknowledge the support of Abbvie: this study was conducted with an unrestricted grant from Abbvie. The Spanish Society of Rheumatology is the sponser and funder of this study and the journal's Rapid Service Fee, and has participated in the study design; in the analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. The corresponding author had full access to all study data and had final responsibility for the decision to submit the manuscript for publication.es_ES
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectuveitises_ES
dc.subjectcomposite indexes_ES
dc.subjectocular inflammationes_ES
dc.subjectconstruct validityes_ES
dc.subjectcriterion validityes_ES
dc.subjectUVEDAIes_ES
dc.titleValidation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© The Author(s) 2023, corrected publication 2023. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://link.springer.com/article/10.1007/s40123-023-00654-8es_ES
dc.identifier.doi10.1007/s40123-023-00654-8
dc.departamentoesDermatología, oftalmología y otorrinolaringologíaes_ES
dc.departamentoeuDermatologia, oftalmologia eta otorrinolaringologiaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© The Author(s) 2023, corrected publication 2023. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Except where otherwise noted, this item's license is described as © The Author(s) 2023, corrected publication 2023. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.